• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

NGQ1:GR

1.358 EUR 0.007 0.52%

As of 15:18:24 ET on 12/23/2014.

Snapshot for Medicure Inc (NGQ1)

Open: 1.360 Day's Range: 1.358 - 1.408 Volume: 0
Previous Close: 1.351 52wk Range: 0.137 - 1.999 1-Yr Rtn: +921.05%

Stock Chart for NGQ1

No chart data available.
  • NGQ1:GR 1.408
  • 1D
  • 1M
  • 1Y
1.351
Interactive NGQ1 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NGQ1

Current P/E Ratio (ttm) -
Estimated P/E(05/2015) 16.0142
Relative P/E vs. DAX -
Earnings Per Share (CAD) (ttm) -
Est. EPS (CAD) (05/2015) 0.1200
Est. PEG Ratio -
Market Cap (M EUR) 16.58
Shares Outstanding (M) 12.21
30 Day Average Volume 33
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 01/28/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NGQ1

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for NGQ1

Medicure Inc. is a cardiovascular drug discovery and development company focused on developing therapeutics for unmet needs in the field of cardiovascular medicine. The Company's current focus is on the prevention and treatment of ischemia, ischemic reperfusion injury, and stroke.

Albert D FriesenChairman/CEO/FounderDawson J ReimerPresident/COO
James F KinleyCFO/Secretary
More Company Profile & Key Executives for NGQ1

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil